Phio Pharmaceuticals Statistics Share Statistics Phio Pharmaceuticals has 4.8M
shares outstanding. The number of shares has increased by 176.96%
in one year.
Shares Outstanding 4.8M Shares Change (YoY) 176.96% Shares Change (QoQ) 0% Owned by Institutions (%) 4.22% Shares Floating 4.45M Failed to Deliver (FTD) Shares 4,827 FTD / Avg. Volume 0.51%
Short Selling Information The latest short interest is 262.23K, so 4.58% of the outstanding
shares have been sold short.
Short Interest 262.23K Short % of Shares Out 4.58% Short % of Float 4.61% Short Ratio (days to cover) 1.48
Valuation Ratios The PE ratio is -1.98 and the forward
PE ratio is -2.53.
Phio Pharmaceuticals's PEG ratio is
0.02.
PE Ratio -1.98 Forward PE -2.53 PS Ratio 0 Forward PS n/a PB Ratio 3 P/FCF Ratio -1.99 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Phio Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.65,
with a Debt / Equity ratio of 0.
Current Ratio 5.65 Quick Ratio 5.65 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.43M Employee Count 5 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -22.4% in the
last 52 weeks. The beta is 0.95, so Phio Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.95 52-Week Price Change -22.4% 50-Day Moving Average 2.22 200-Day Moving Average 2.06 Relative Strength Index (RSI) 58.16 Average Volume (20 Days) 951,041
Income Statement
Revenue n/a Gross Profit -35K Operating Income -7.39M Net Income -7.15M EBITDA -7.12M EBIT -7.15M Earnings Per Share (EPS) -0.91
Full Income Statement Balance Sheet The company has 5.38M in cash and 0 in
debt, giving a net cash position of 5.38M.
Cash & Cash Equivalents 5.38M Total Debt n/a Net Cash n/a Retained Earnings -146.36M Total Assets 11.3M Working Capital 10.09M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.11M
and capital expenditures -1K, giving a free cash flow of -7.11M.
Operating Cash Flow -7.11M Capital Expenditures -1K Free Cash Flow -7.11M FCF Per Share -0.9
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PHIO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PHIO is $14,
which is 485.8% higher than the current price. The consensus rating is "Buy".
Price Target $14 Price Target Difference 485.8% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 5, 2024. It was a
backward
split with a ratio of 1:9.
Last Split Date Jul 5, 2024 Split Type backward Split Ratio 1:9
Scores Altman Z-Score -14.35 Piotroski F-Score 3
